CombiMatrix Q4 Revenues Climb 52 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CombiMatrix today reported that its fourth-quarter revenues rose 52 percent year over year.

For the three months ended Dec. 31, 2011, revenues totaled $1.2 million, compared to $804,000 a year ago as diagnostic services revenues, which comprised all of CombiMatrix's revenues in Q4 2011, increased 55 percent from $791,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.